Monitor the next 10-K for Bush & Associates' audit opinion and any material weaknesses or going concern disclosures that may surface under the new auditor.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 9 $5.19entry
- T+1 · 7d ago +2.89%α +3.26% · $5.34
- T+5 · 18h ago −18.30%α −16.61% · $4.24
- T+20 · in 21d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Shuttle Pharmaceuticals dismissed Forvis Mazars, LLP as its auditor and engaged Bush & Associates CPA LLC as the new independent registered public accounting firm. The filing states no disagreements or reportable events with the former auditor, and no prior consultations with the new auditor occurred. Auditor changes at micro-cap companies often raise governance concerns, but the filing contains no disclosed disagreements or adverse opinions.
Key Facts
- Forvis Mazars, LLP was dismissed as auditor effective after the Q3 2026 10-Q filing.
- Bush & Associates CPA LLC was engaged on November 2, 2026, with an engagement letter dated October 19, 2026.
- No disagreements or reportable events were reported between the company and Forvis Mazars.
- The company did not consult Bush & Associates on accounting principles or audit opinions prior to engagement.
- Bush & Associates will audit FY 2026 and review interim periods through September 2027.
Financial Impact
No financial figures disclosed; auditor change at a $25M market cap company with no stated disagreements.
Risk Factors
- Auditor changes at micro-cap companies can signal undisclosed accounting issues or financial distress.
- Bush & Associates is a smaller firm, which may indicate reduced audit scrutiny or difficulty retaining a Big 4 auditor.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001493152-26-050532 |
| Document: 0001493152-26-050532-index-headers.html | 0001493152-26-050532 |
| Document: 0001493152-26-050532-index.html | 0001493152-26-050532 |
| Document: 0001493152-26-050532.txt | 0001493152-26-050532 |
Track record
9 reports on SHPH
2 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +59.68% at T+60 after the May 1, 2026 report. 2 of 3 went positive at some point.
Filters
- Nov 6, 202610d ago 8-K Neutral 4/10 Viewing Entry $5.19 to $4.24 Now $4.24 −18.30% ▼ −18.30% −16.61% vs SPY
- Oct 22, 202625d ago 8-K Bearish 6/10 Entry $4.86 to $5.15 Now $4.24 +12.76% ▼ −5.97% −6.53% vs SPY
- Sep 1, 202610w ago 8-K Neutral 2/10 Entry $3.49 to $3.53 Now $4.24 +21.49% ▲ +1.15% +2.10% vs SPY
- Jul 13, 202618w ago 3 Neutral 2/10 Entry $2.96 to $3.16 Now $4.24 +43.24% ▲ +6.76% +7.54% vs SPY
- Jul 1, 202619w ago 3 Neutral 2/10 Entry $3.58 to $3.28 Now $4.24 +18.44% ▼ −8.38% −9.31% vs SPY
- Jun 11, 202622w ago 8-K Neutral 3/10 Entry $3.91 to $3.46 Now $4.24 +8.44% ▼ −11.51% −12.18% vs SPY
- May 7, 202627w ago 8-K Bearish 8/10 Entry $6.89 to $6.66 Now $4.24 +38.46% ▲ +3.34% +3.55% vs SPY
- May 1, 202628w ago 8-K Bearish 7/10 Entry $6.92 to $6.89 Now $4.24 +38.73% ▲ +0.43% +2.79% vs SPY
- Mar 10, 202635w ago 8-K Neutral 4/10 Entry $0.9010 to $0.9990 Now $4.24 +370.59% ▲ +10.88% +13.07% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers